|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of 1 Critical Care Medicine, 2 Surgery, and 4 Pathology and 3 The Center for Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260
| |
ABSTRACT |
|---|
|
|
|---|
We sought to determine whether gut-derived microbial factors influence the hepatic or intestinal inflammatory response to hemorrhagic shock and resuscitation (HS/R). Conventional and gnotobiotic mice contaminated with a defined microbiota without gram-negative bacteria were subjected to either a sham procedure or HS/R. Tissue samples were obtained 4 h later for assessing ileal mucosal permeability to FITC dextran and hepatic and ileal mucosal steady-state IL-6, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, and TNF mRNA levels. Whereas HS/R significantly increased ileal mucosal permeability in conventional mice, this effect was not apparent in gnotobiotic animals. HS/R markedly increased hepatic mRNA levels for several proinflammatory genes in both conventional and gnotobiotic mice. HS/R increased ileal mucosal IL-6 and COX-2 mRNA expression in conventional but not gnotobiotic mice. If gnotobiotic mice were contaminated with Escherichia coli C25, HS/R increased ileal mucosal permeability and upregulated expression of IL-6 and COX-2. These data support the view that the hepatic inflammatory response to HS/R is largely independent of the presence of potentially pathogenic gram-negative bacteria colonizing the gut, whereas the local mucosal response to HS/R is profoundly influenced by the microbial ecology within the lumen during and shortly after the period of hemorrhage.
translocation; bacterial; permeability; mucosal; tumor necrosis factor; cyclooxygenase-2; inducible nitric oxide synthase; interleukin-6
| |
INTRODUCTION |
|---|
|
|
|---|
THE PATHOLOGICAL MECHANISMS underlying the development of multiple organ dysfunction in victims of trauma and hemorrhagic shock (HS) remain poorly understood. Nevertheless, a widely held view is that poorly controlled systemic activation of the inflammatory response somehow leads to cellular dysfunction and/or destruction in various organs, including the liver, lungs, and kidneys. Although a large body of data supports the idea that the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) are causally related, the SIRS/MODS model is insufficient by itself to explain some common clinical observations. For example, some victims of major trauma and of HS and resuscitation (HS/R) are fortunate and recover relatively uneventfully. Others, however, suffer complications such as acute respiratory failure, azotemia, jaundice, and systemic infection. Of course, the likelihood of developing MODS depends, in part, on the magnitude of the initial insult (50). Nevertheless, because the magnitude of the initial stressful event fails to reliably predict the occurrence of MODS, it seems probable that one or more other, possibly host-related, factors is also involved. One of these additional factors may be the leakage of bacteria or microbial products, notably lipopolysaccharide (LPS), from the lumen of the gut into the systemic compartment, leading to the initiation or amplification of a deleterious inflammatory response. This view is supported by results from a number of clinical studies, which have documented increases in intestinal epithelial permeability in a variety of acute conditions, including trauma and HS/R (28, 36, 41). Moreover, in several recent studies, increased intestinal permeability has been shown to be associated with an increased risk of complications, MODS, or even mortality (2, 13, 15, 40).
Despite these observations, only very limited data are available to support a direct link between gut-derived microbes or microbial products and the inflammatory response in distant organs after HS/R (6, 19, 64, 67). One might presume that the most direct way to test the leaky gut hypothesis in the laboratory would be to compare the effects of HS/R in normal and germ-free animals, using markers of systemic inflammation and/or organ injury as the readouts. Indeed, some previous studies have employed just this strategy (16, 21, 22, 31, 38, 48, 68). However, numerous structural and functional immunological abnormalities are present in animals that have been maintained under truly germ-free conditions (5, 7, 9, 39). Accordingly, drawing inferences about alterations in the inflammatory response after HS/R related to the absence of microbes in the intestine could be confounded by preexisting immunological abnormalities.
One way to minimize some of the concerns regarding the use of germ-free animals is to employ gnotobiotic mice colonized with a defined microbiota called the altered Schaedler flora (51). These animals are born by cesarian delivery and raised in a germ-free environment but are deliberately contaminated with eight strains of bacteria with low pathogenic potential. The eight strains consist of the following: two strains of Lactobacillus (ASF 361 and ASF 360); a strain closely related to the genus Porphyromonas (ASF 360); a spiral-shaped strain in the Flexistipes phylum (ASF 457); and four strains of extremely oxygen-sensitive fusiform gram-positive bacteria (ASF 356, ASF 492, ASF 502, and ASF 500). Unlike germ-free animals, gnotobiotic mice colonized with various bacterial strains with low pathogenic potential manifest relatively normal resistance to opportunistic bacteria (20) and other aspects of immunological responsiveness, such as the number of IgA-secreting lymphocytes in the intestinal mucosa (26, 35). Thus studies using gnotobiotic mice carrying the Schaedler flora might provide a more clinically relevant model for testing the role of gut-derived pathogenic bacteria in the pathogenesis of organ system injury and inflammation after resuscitation from HS.
Accordingly, in the present study, we subjected conventional and
gnotobiotic (ASF contaminated) black Swiss mice to HS/R. Whereas HS/R
significantly increased ileal mucosal permeability to a hydrophilic
macromolecular tracer, fluorescein-labeled dextran with an average
molecular mass of 4,000 Da (FD4), in conventional mice, this effect was
not apparent in gnotobiotic animals. HS/R activated the proinflammatory
transcription factor NF-
B in liver in both conventional and
gnotobiotic mice. Similarly, HS/R markedly increased hepatic
steady-state mRNA levels for several proinflammatory genes in both
conventional and gnotobiotic mice. In contrast, HS/R increased ileal
mucosal IL-6 and cyclooxygenase-2 (COX-2) mRNA expression in
conventional but not gnotobiotic mice. Collectively, these data support
the view that the hepatic inflammatory response to HS/R is largely
independent of the presence of potentially pathogenic gram-negative
bacteria colonizing the gut, whereas the local mucosal response to HS/R
is profoundly influenced by the microbial ecology within the lumen
during the period of hemorrhage and resuscitation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
This research protocol complied with the regulations regarding animal care as published by the National Institutes of Health and was approved by the Institutional Animal Use and Care Committee of the University of Pittsburgh Medical School. Male black Swiss wild-type and gnotobiotic mice, age 4-8 wk, were obtained from Taconic (Germantown, NY). The wild-type animals were maintained at the University of Pittsburgh Animal Research Center with a 12:12-h light-dark cycle and free access to standard laboratory feed and water. The gnotobiotic mice were kept in a sterilized facility with free access to germ-free food and water. Animals were not fasted before the experiments. All chemicals were purchased from Sigma-Aldrich Chemical (St. Louis, MO) unless otherwise noted.
Experimental design for animal experiments.
Pilot studies using 30 conventional mice were carried out to determine
the optimal time after resuscitation to maximize the signal for the
primary readout of interest (ileal mucosal permeability) while
minimizing the loss of animals due to mortality induced by the HS/R
protocol. After completing these pilot experiments, four groups of mice
(n = 8 each) were studied for the main series of
experiments. The two sham-shock groups (conventional and gnotobiotic) were anesthetized but subjected neither to shock nor resuscitation. The
two HS/R groups (conventional and gnotobiotic) were subjected to HS and
resuscitated with shed blood and Ringer lactate solution (RLS). The
shock model employed has been described in detail previously (65). Briefly, mice were anesthetized using intramuscular
pentobarbital sodium (90 mg/kg). Both femoral arteries were surgically
prepared and cannulated. The left artery was used for continuous blood pressure monitoring. The right artery was used for blood withdrawal and
blood and fluid administration. The mice were subjected to HS by
withdrawal of blood (2.25 ml/100 g body wt) over 10 min to achieve a
mean arterial pressure (MAP) of 30 mmHg. MAP was maintained at 30 mmHg
for 2.0 h with continuous monitoring of blood pressure and
withdrawal and return of blood as needed. Cannulas, syringes, and
tubing were flushed with heparin sodium (1,000 U/ml) before all
procedures. The animals were resuscitated to an initial MAP
80 mmHg by administration of all remaining shed blood plus intra-arterial
injection of 2× shed blood volume of RLS over 30 min. Sham controls
were subjected to the same anesthetic and cannulation procedures but
were not subjected to HS. Four hours after resuscitation (or sham
shock), surviving mice were reanesthetized with intramuscular pentobarbital sodium (90 mg/kg), and the following procedures were
performed: a segment of ileum was harvested for determination of
mucosal permeability; the mesenteric lymph node (MLN) complex was
harvested to measure bacterial translocation; blood was aspirated from
the heart to measure the plasma concentration of alanine aminotransferase (ALT); and portions of the liver and ileum were harvested for determination of NF-
B activation using electrophoretic mobility shift assay (EMSA) and/or expression of proinflammatory genes
using semiquantitative RT-PCR.
Intestinal mucosal permeability. Intestinal mucosal permeability to the fluorescent tracer FITC dextran with a molecular mass of 4,000 Da (FD4) was determined using an everted gut sac method, as previously described by Wattanasirichaigoon et al. (62) and modified by Yang et al. (65) for use with mice. Everted gut sacs were prepared in ice-cold modified Krebs-Henseleit bicarbonate buffer (KHBB, pH 7.4). One end of the gut segment was ligated with a 4-0 silk suture. The segment was then everted onto a thin plastic rod, and the resulting gut sac was secured with a 4-0 silk suture to the grooved tip of a 3-ml plastic syringe containing KHBB. The sac was gently distended by injecting 1.5 ml of KHBB. The sac was suspended in a 50-ml beaker containing 40 ml of KHBB plus FD4 (40 mg/ml). The solution in the beaker was temperature jacketed at 37°C and was continuously bubbled with a gas mixture containing 95% O2-5% CO2. A 1.0-ml sample was taken from the beaker before putting in the gut sac to determine the initial external (i.e., mucosal surface) FD4 concentration. The sac was incubated for 30 min in the KHBB solution containing FD4. The length of the gut sac was measured. Fluid from the inside of the sac was aspirated for the determination of FD4 concentration. The serosal and mucosal samples were centrifuged for 10 min at 10,000 g. Three hundred microliters of the supernatant was diluted with PBS (2.7 ml). Fluorescence was measured using a Perkin-Elmer LS-50 fluorescence spectrophotometer (Palo Alto, CA) at an excitation wavelength of 492 nm (slit width = 2.5 nm) and an emission wavelength of 515 nm (slit width = 10 nm). Permeability was expressed as the mucosal-to-serosal clearance of FD4 as previously described (65).
Bacterial translocation. The skin was cleaned with 10% povidone-iodine. Using sterile technique, the abdominal cavity was opened and the viscera exposed. The MLN complex was removed, weighed, and placed in a grinding tube containing 0.5 ml of ice-cold PBS. The MLN were homogenized with glass grinders, and a 250-µl aliquot of the homogenate was plated onto brain-heart infusion and MacConkey's agar (Becton Dickinson, Sparks, MD). The plates were examined 24 h later after being aerobically incubated at 37°C. The colonies were counted, and results are expressed as colony forming units per gram of tissue.
Serum ALT measurement. Two hundred microliters of blood was obtained by cardiac puncture and placed in a 0.5-ml centrifugation tube on ice. The samples were then centrifuged at 5,000 g for 3 min. The serum was collected and assayed for ALT using an automated assay system.
Immunohistochemistry. Tissues were fixed in 2% paraformaldehyde for 1 h, then treated with 30% sucrose overnight. Fixed sections were washed three times in PBS containing 0.5% BSA and 0.15% glycine, pH 7.4 (buffer A). The fixed and washed sections were incubated for 30 min with purified goat IgG (50 mg/ml) at 25°C and then washed three more times with buffer A. All the preceding steps were designed to ensure minimal nonspecific reaction to the antibodies used. Sections were then incubated for 60 min with a primary antibody to iNOS (1 µg/ml; Transduction Laboratories, Newcastle, UK). This step was followed by three washes in buffer A and a 60-min incubation with a fluorescently labeled second antibody (Alexa 488, 1-2 mg/ml; Molecular Probes, Eugene, OR) mixed with buffer A. The sections were then washed six times (5 min/wash) in buffer A, washed for 1 min in PBS containing 4',6-diamidino-2-phenylindole dihydrochloride (DAPI), a UV-excited DNA stain to delineate nuclei, and then mounted in gelvatol and placed under coverslips for light microscopy. Observation was with an Olympus Provis microscope equipped with a cooled CCD camera.
Assessment of NF-
B activation.
DNA binding of NF-
B was assessed using the EMSA as previously
described by our laboratory (65). To prepare nuclear
extracts, murine tissue samples were homogenized with T-PER (Pierce,
Rockford, IL), using a 1:20 ratio of tissue to the sample preparation
reagent, as directed by the manufacturer's instructions. The samples
were centrifuged at 10,000 g for 5 min to pellet tissue
debris. The supernatant was collected and frozen at
80°C. Nuclear
protein concentration was determined using a commercially available
Bradford assay (Bio-Rad, Hercules, CA).
B nuclear binding was performed using a duplex
oligonucleotide probe based on the NF-
B binding site upstream of the
murine iNOS promoter. The sequence of the double-stranded NF-
B
oligonucleotide was as follows: sense 5'-AGT TGA GGG GAC TTT CCC AGG
C-3'; antisense 3'-TCA ACT CCC CTG AAA GGG TCC G-5' (Promega; Madison,
WI). The oligonucleotides were end-labeled with
[
-32P]ATP (New England Nuclear; Boston, MA) using T4
polynucleotide kinase (Promega). Six micrograms of nuclear protein was
incubated at room temperature with
-32P-labeled NF-
B
probe in 4 µl of 5× binding buffer (65 mM HEPES, 325 mM NaCl, 5 mM
DTT, 0.7 mM EDTA, 40% glycerol, pH 8.0) in the presence of 2 µg of
poly(dI-dC) for 20 min; the total volume of the binding
reaction mixture was 20 µl. The binding reaction mixture was
electrophoresed on 4% nondenaturing PAGE gels. After electrophoresis, the gels were dried and exposed to Kodak (Rochester, NY) X-Omat film at
80°C. The autoradiograms were quantified by scanning densitometry.
To determine the specificity of binding reactions, cold competition
studies were carried out using a 100-fold molar excess of either
unlabeled NF-
B duplex oligonucleotide (specific competition) or an
irrelevant oligonucleotide probe. For the latter, we used a probe
containing the hypoxia inducible factor (HIF)-1 binding sequence from
the human erythropoeitin 3'-enhancer. Supershift assays were performed
by incubating nuclear extracts with 2 µl of anti-p65 and anti-p50
antibodies (Santa Cruz Biotechnology; Santa Cruz, CA) for 1 h
before the addition of radiolabeled probe. The binding reaction mixture
was electrophoresed on 4% PAGE gels. After electrophoresis, the gels
were dried and exposed to XAR-5 film (Kodak; Rochester, NY) at
80°C
for overnight using an intensifying screen.
RT-PCR. Steady-state levels of TNF, iNOS, COX-2, and IL-6 mRNA were estimated using semiquantitative RT-PCR, using methods and primers that have been previously reported in detail by our group (65).
Statistical methods. In general, results are presented as means ± SE. Results from studies to estimate bacterial translocation were not normally distributed and included a few outlying values. Accordingly, these data are presented as median values, and the differences between groups were analyzed using Wilcoxon's U-test. Other continuous data were analyzed using Student's t-test or ANOVA followed by Fisher's least significant difference (LSD) test, as appropriate. P values < 0.05 were considered significant. Summary statistics are presented for densitometry results from studies using RT-PCR to estimate mRNA expression, but these results were not subjected to statistical analyses since the method employed was only semiquantitative and the samples sizes (n = 3 or 4) were small (65).
| |
RESULTS |
|---|
|
|
|---|
Pilot studies using conventional mice. MAP was maintained at 30 mmHg for 2.0 h in all animals before initiating resuscitation. Survival was 8/8 (100%) at 30 min after starting resuscitation, 9/12 (75%) at 4 h after resuscitation, and 5/10 (50%) at 24 h after resuscitation. Ileal mucosal permeability to FD4 was similarly increased at 4 and 24 h after resuscitation. Accordingly, detailed studies were carried out using the 2-h hemorrhage plus 4-h resuscitation model.
Intestinal barrier dysfunction.
Although ileal mucosal permeability to FD4 tended to be somewhat higher
in sham-hemorrhaged gnotobiotic compared with conventional mice, the
difference was not consistent enough to achieve statistical significance (Fig. 1). Subjecting
conventional mice to HS/R significantly increased ileal mucosal
permeability to FD4. In contrast, when gnotobiotic mice were subjected
to HS/R, ileal mucosal permeability was not affected. As expected,
bacterial translocation to MLN was minimal in sham-hemorrhaged animals,
irrespective of whether they were maintained under conventional or
gnotobiotic conditions; median values were 0 CFU per g of MLN tissue in
both groups. The number of aerobic or facultative anaerobic CFUs in MLN
increased significantly in conventional mice subjected to HS/R (median
value = 714 CFU/g) but not in gnotobiotic mice subjected to the
same insult (median value = 0 CFU/g; P < 0.05 vs.
conventional group).
|
Hepatocellular damage.
The mean plasma ALT concentration increased significantly after HS/R in
both conventional and gnotobiotic mice (Fig.
2). Although the circulating levels of
ALT tended to be lower after HS/R in gnotobiotic compared with
conventional animals, the difference was not sufficiently reproducible
to achieve statistical significance.
|
NF-
B activation.
We used EMSA to detect DNA binding by the transcription factor NF-
B
in nuclear extracts prepared from samples of liver and ileal tissue
obtained from conventional and gnotobiotic mice 4 h after
resuscitation from HS or at a similar time after the sham procedure. As
noted previously by our laboratory (65) and others (44), there was a high level of basal DNA binding of
NF-
B in samples of ileal mucosa. After resuscitation from HS/R,
NF-
B DNA binding increased in liver tissue (Fig.
3) but was unchanged in ileal mucosa.
Hepatic post-HS/R NF-
B DNA binding was similar in conventional and
gnotobiotic mice. As in a recent previous report from our group
(65), we carried out studies to confirm the identity of
the activated protein-DNA complex. Binding of the protein to the
radioactive consensus NF-
B binding element was completely inhibited
by a 100-fold excess of unlabeled NF-
B duplex oligonucleotide but
not by a similar molar excess of the consensus binding sequence for
HIF-1, an irrelevant duplex oligonucleotide. Supershift assays were
carried out using samples that were preincubated with specific
antibodies directed against p50 and p65. As in a previous report from
our laboratory (65), we failed to observe a supershift
with the anti-p50 antibody but observed decreased intensity of the main
NF-
B band with the p65 antibody and evidence of a supershifted
complex.
|
Expression of inflammatory genes.
We used semiquantitative RT-PCR to estimate steady-state mRNA levels
for several inflammatory genes. 18S RNA was used as an internal control
to document equal loading of RNA. Hepatic IL-6, iNOS, COX-2, and (to a
lesser extent) TNF steady-state mRNA levels increased to a similar
degree after HS/R in both conventional and gnotobiotic mice (Fig.
4). In other words, the gnotobiotic state
had little or no influence on the hepatic expression of several
inflammatory genes after HS/R. In ileal mucosa, however, the
gnotobiotic state had a clear effect on the post-HS/R expression of
IL-6 and COX-2 and a lesser effect on the post-HS/R expression of iNOS
and TNF (Fig. 5). Specifically, whereas
ileal mucosal expression of IL-6 and COX-2 increased substantially in
conventional mice after HS/R, ileal mucosal steady-state levels of IL-6
and COX-2 mRNA were very low in both sham-treated gnotobiotic mice and
gnotobiotic mice subjected to HS/R. There was a relatively small
increase in ileal mucosal iNOS and TNF expression in conventional mice
after HS/R. However, in gnotobiotic mice, steady-state iNOS and TNF
mRNA levels were very low in mice subjected to either the sham
procedure or HS/R.
|
|
Immunohistochemistry.
In conventional mice, HS/R was associated with increased staining of
hepatic parenchyma (Fig. 6) and ileal
mucosa (Fig. 7) for iNOS. In
gnotobiotic mice, HS/R was associated with increased staining of liver
tissue for iNOS. However, staining for iNOS in ileal mucosa was
decreased in gnotobiotic animals, both after sham manipulation and,
particularly, after HS/R.
|
|
Effect of HS/R in gnotobiotic mice contaminated with E. coli C25.
We were impressed that HS/R in gnotobiotic mice caused minimal
changes in ileal mucosal permeability or the expression of several
stress-related genes in samples of ileal mucosa. We considered two
alternative hypotheses to explain these observations. First, gnotobiotic animals might have an intrinsic alteration in their capacity to mount an innate immune response to a proinflammatory stimulus. Alternatively, alterations in the microflora within the lumen
of the gut, such as the absence of gram-negative bacteria, in
gnotobiotic mice might prevent the development of mucosal inflammation after HS/R. To test this latter hypothesis, we carried out an additional series of experiments, wherein gnotobiotic mice were acutely
contaminated with E. coli C25 18 h before being
subjected to HS/R. Compared with uncontaminated gnotobiotic mice
subjected to HS/R, E. coli C25-contaminated gnotobiotic mice
manifested increased ileal mucosal permeability to FD4 (Fig.
8) as well as increased expression of
several proinflammatory genes, most notably IL-6 and COX-2
(Fig. 9) after HS/R.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The notion that leakage of microbes or microbial toxins from the gut into the systemic compartment might contribute to systemic illness in HS/R is far from novel. Indeed, versions of this concept have been appearing in the biomedical literature for many years. As early as 1903, the Russian biologist Metchnikoff (32) suggested that the systemic absorption of microorganisms or their products from the gastrointestinal tract could lead to mortality. Subsequently, in 1923, the great Harvard physiologist Walter B. Cannon suggested that a toxic factor originating from the gut was responsible for the development of irreversibility in cases of prolonged, profound HS (8). During the 1950s and 1960s, Jacob Fine (17) promoted the idea that endotoxin derived from intraluminal gram-negative bacteria was the gut-derived toxic factor responsible for irreversibility in HS. In support of this concept, Fine and his co-workers amassed a huge corpus of experimental evidence. For example, these workers showed that using antibiotics to decontaminate the gastrointestinal tract could improve mortality in animals subjected to HS (18, 24) and documented the appearance of endotoxin in the circulation during shock (47). Fine's concept was further supported by results from an elegant, if complex, study performed by Lillehei (29), who showed that irreversibility was prevented in dogs subjected to HS, when oxygenated blood from healthy unshocked animals was used to maintain normal intestinal (but not hepatic) perfusion during the period of hypotension in the animals subjected to bleeding.
The work by Fine and colleagues was repudiated by Zweifach and colleagues (38, 68) and others (21, 31), who showed that mortality rates after HS/R were similar in conventional animals and animals raised under germ-free conditions. Fine et al. (17) argued that these results were explainable because the food fed to the germ-free animals contained sufficient LPS to cause systemic contamination during hemorrhage, a view that was substantiated many years later by Rush and colleagues (48). Indeed, Fine's whole concept that gut-derived bacteria and/or toxins play a crucial role in the pathogenesis of HS/R-induced mortality or MODS was revived during the 1980s and 1990s by numerous investigators. The reawakening of interest in the "leaky gut" hypothesis was partly prompted by results from some pivotal studies (16, 22, 48), which contradicted the earlier data reported by Zweifach and others (21, 31, 38, 68) by showing that long-term survival after HS/R is significantly better in germ-free compared with conventional rats.
A number of other fairly recent findings can be cited to support the notion that a gut-derived microbial factor, notably LPS, contributes to the development of distant inflammation, MODS, and/or mortality after HS/R. For example, Guo et al. (19) reported that post-HS/R plasma IL-6 and TNF levels are lower in rats whose gut flora has been decontaminated by pretreatment with oral antibiotics compared with rats with normal gut flora. Similarly, Yamashita (64) showed that pretreatment of rats with recombinant human bactericidal/permeability-increasing protein (BPI), a compound that is known to bind and neutralize LPS, attenuates HS/R-induced increases in TNF, IL-6, and plasminogen activator inhibitor-1 mRNA levels. Along these same lines, survival after HS/R is improved when rats are pretreated with BPI (66) or a monoclonal antibody to LPS (4) or an antibiotic known to bind and neutralize LPS, polymyxin B (67). Furthermore, circulating TNF levels are significantly higher, elevated blood lactate levels persist longer, and mortality is significantly greater in endotoxin-sensitive C3H/HeN compared with endotoxin-resistant C3H/HeJ mice subjected to HS/R (12, 42).
In contrast to these observations, other recent data support the view that gut-derived microbial toxins are not important in the pathogenesis of MODS and/or mortality after HS/R. For example, Ayala et al. (3) were unable to detect circulating LPS at any time points between 2 and 24 h after HS/R in mice. Similar findings have been reported from studies of patients admitted to the hospital with HS or major trauma (14, 34). Moreover, HS/R was associated with profound alterations in myelopoiesis in both germ-free and conventional rats (30).
The data presented herein support the view that the presence of normal
intestinal microflora is not a major factor contributing to the early
hepatic (distant) inflammatory response to HS/R. Activation of the
important proinflammatory transcription factor NF-
B was similar in
both conventional and gnotobiotic mice. Furthermore, steady-state
levels of several proinflammatory genes increased after HS/R to a
similar extent in liver tissue in both conventional and gnotobiotic
mice. Consistent with these findings, we found that the degree of early
HS/R-induced hepatocellular injury (as assessed by leakage of the
enzyme ALT into plasma) was also similar in conventional and
gnotobiotic mice.
At least two explanations might account for these findings. First,
injury and inflammation in the liver during and after hemorrhage is
probably initiated, at least in part, by tissue ischemia and redox stress. Certainly, it is well established that HS/R is associated with the release of potent oxidants in the liver and other organs (25, 33, 37, 52, 57). Moreover, redox-mediated events have
been implicated in the pathogenesis of the inflammatory response after
HS/R (52, 65), possibly as a result of activation of the
important proinflammatory transcription factor NF-
B (1, 53-55, 65). Reactive oxygen species (ROS) also have been
implicated in activating other proinflammatory signaling pathways. For
example, activation of activator protein (AP)-1 is at least partially
redox dependent (27, 45, 46). Modifying the microflora in
the gut would not be expected to modulate redox-mediated activation of
these important proinflammatory signaling pathways.
An alternative explanation for the similar degree of hepatic inflammation and injury reported here in gnotobiotic and conventional mice subjected to HS/R has already been alluded to above. Specifically, although the gnotobiotic animals used in this study were maintained under strict germ-free conditions and were fed sterilized chow, no efforts were made to remove LPS from the diet supplied to these animals. Accordingly, the presence of LPS in the lumen of the gut, rather than the presence or absence of normal intestinal microflora, may be the key determinant of hepatocellular injury or activation of hepatic proinflammatory genes after HS/R.
Although colonization of mice with the altered Schaedler flora rather than the range of microbes normally found in the lumen of gut failed to modulate hepatocellular injury or hepatic expression of proinflammatory genes after HS/R, the gnotobiotic condition was associated with a marked alteration in the intestinal mucosal (local) response to this stressful perturbation. We observed a fourfold increase in ileal mucosal permeability to the hydrophilic macromolecule FD4 when gut sacs were harvested from conventional mice 4 h after HS/R. This finding is entirely consistent with previous observations reported by our laboratory (61, 63) and other groups (49). In contrast, when gnotobiotic mice were subjected to HS/R, intestinal permeability to FD4 did not increase at all. When we analyzed ileal mucosal samples using semiquantitative RT-PCR, we observed consistent increases after HS/R in steady-state mRNA levels for several proinflammatory genes. This HS/R-induced upregulation of proinflammatory genes was not observed in similar samples obtained from gnotobiotic animals.
Our observations regarding the effect of the gnotobiotic state on the intestinal mucosal response to HS/R are consistent with (at least) two possible mechanisms. First, it is well known that the immune system in germ-free mice is markedly abnormal (5, 7, 9, 39) and that the release of a number of cytokines is impaired in mice born and maintained under perfectly sterile conditions (23). Even gnotobiotic mice (i.e., mice colonized with a defined but abnormal microflora) such as the ones used for the present study are not entirely normal immunologically (35). Accordingly, the failure of HS/R to alter either gut mucosal barrier function or the expression of several proinflammatory genes in gnotobiotic mice could have been due to defects in the immune system in these animals. Alternatively, alterations in the microflora within the lumen of the gut, such as the absence of gram-negative bacteria, in gnotobiotic mice might have directly interfered with the development of mucosal inflammation after HS/R. To test this latter hypothesis, we carried out an additional series of experiments, wherein gnotobiotic mice were contaminated with E. coli C25 18 h before being subjected to the HS/R protocol. Compared with uncontaminated gnotobiotic mice, E. coli C25-contaminated gnotobiotic mice manifested both increased ileal mucosal permeability to FD4 as well increased expression of IL-6 and COX-2 and, to a lesser extent, iNOS and TNF. These findings suggest that intestinal inflammation after HS/R is dependent on the presence of one or more microbial products that are produced by E. coli C25 (as well as the microbes found in the intestine of coventional mice) but are not produced by the microflora in gnotobiotic mice carrying the altered Schaedler flora. Our data are insufficient to determine whether enteral contamination of gnotobiotic mice with strains of bacteria other than E. coli C25 would have produced similar effects. Furthermore, it is noteworthy that the 70% increase in ileal mucosal permeability induced by HS/R in gnotobiotic mice contaminated with E. coli C25 was less than the 350% increase in permeability induced by HS/R in conventional mice. Thus it is likely that acute enteral contamination with a single gram-negative strain was not sufficient to completely normalize the ileal mucosal response to HS/R in gnotobiotic animals. Other bacterial strains or other unrelated factors may contribute to the failure of HS/R to cause ileal mucosal hyperpermeability in gnotobiotic mice.
Although it is well established that ileal mucosal permeability increases in conventional mice subjected to hemorrhage (49) or HS/R (10, 11, 58, 60, 63, 65), the fundamental mechanisms that are responsible for this phenomenon remain to be elucidated. Some data suggest that oxidant stress may be an important factor, because HS/R-induced structural or functional mucosal damage can be ameliorated in some models by timely administration of compounds capable of scavenging ROS (10, 37, 58, 65). Other data suggest that complement activation, even without ROS-mediated injury, is a key event leading to gut mucosal injury due to HS/R (56). Secretion of the proinflammatory cytokine IL-6 may be another important factor. Wang et al. (60) reported that HS/R is associated with increased systemic arterial and portal venous plasma levels of IL-6. Moreover, these authors showed that plasma IL-6 levels correlate with gut mucosal permeability in this model, suggesting that IL-6 may be an important factor contributing to intestinal epithelial dysfunction secondary to HS/R. This notion is supported by data obtained by Wang et al. (59), showing that sepsis induces in gut mucosal hyperpermeability in wild-type but not IL-6 knock-out (KO) mice (59). Furthermore, preliminary findings in our laboratory indicate that IL-6 KO mice are also protected from gut mucosal hyperpermeability induced by HS/R (unpublished observations). Prompted by these data, we hypothesize that a bacterial factor that is present in the lumen of conventional but not gnotobiotic mice leads to increased mucosal expression of IL-6 after HS/R. IL-6 release then promotes tight junction dysfunction and epithelial hyperpermeability via mechanisms that remain to be elucidated. Recently reported data suggest that activation of the heat shock response might be important in the pathogenesis of this phenomenon (43).
Our findings regarding the effects of the gnotobiotic state on intestinal mucosal permeability after HS/R are inconsistent with data previously reported by Deitch et al. (11). These authors used a combination of antibiotics to decrease intestinal populations of aerobic and facultative anaerobic bacteria in rats. Normal and antibiotic-decontaminated animals were subjected to HS/R, and intestinal permeability to a macromolecular marker, horseradish peroxidase (HRP), was determined using electron microscopy 2 h later. In this study, HRP was detected in the channels between adjacent enterocytes in normal and antibiotic-decontaminated rats subjected to HS/R but not in sham-hemorrhaged animals. These findings were interpreted as showing that gut-derived microflora are not a factor in the development of mucosal hyperpermeability after HS/R. A number of reasons might account for the variance in the results from this earlier study and the results reported by us here. First, in the earlier study, the period of shock was only 30 min compared with the 2.0-h-long period used by us. Second, Deitch et al. (11) studied rats, whereas we employed mice for our experiments. Third, Deitch et al. (11) used a 40-kDa marker (HRP) for their studies, whereas we used a 4-kDa marker (FD4) for ours. Fourth, the earlier study used a histological readout to detect changes in permeability, whereas we used a functional assay. Finally, and perhaps most important, antibiotic decontamination achieved only about a 10,000-fold reduction in the total number of aerobic and facultative anaerobic bacteria in the cecal contents of rats. Thus, in the study by Deitch et al., the cecal contents of antibiotic-decontaminated rats still contained >1,000 CFU/g of normal intestinal microorganisms. In other words, the strategy of using antibiotics to alter the intestinal flora may not have achieved a sufficient change to alter the intestinal inflammatory response to HS/R.
Ileal mucosal permeability tended to be higher in sham-treated gnotobiotic compared with conventional mice. Although these differences were not quite consistent enough to achieve statistical significance, a strong trend was apparent. To our knowledge, this observation has not been reported before. We speculate that normal maturation of the tight junctions between adjacent intestinal epithelial cells may be dependent in some way on the interaction between the gut's endogenous microflora and the cells forming the mucosa. Alternatively, the stress associated with general anesthesia and surgical manipulation might alter gut mucosal permeability in the sham-hemorrhaged gnotobiotic animals. It was beyond the scope of the present study to pursue the mechanism(s) responsible for this effect. Circulating ALT levels also tended to be higher in gnotobiotic compared with conventional mice subjected to the sham procedure. Again this observation appears to be novel but is also unexplained by the present data and might reflect the stress associated with the sham procedure.
In summary, we showed herein that HS/R was associated with the development of hepatocellular injury and the activation of several proinflammatory genes in the liver tissue of both conventional and gnotobiotic mice. In conventional mice, HS/R was also associated with the development of ileal mucosal hyperpermeability and the activation of proinflammatory genes in intestinal mucosa. These changes were not observed in gnotobiotic mice but were observed in gnotobiotic mice contaminated with a gram-negative organism, E. coli C25. These data support the view that a bacterial factor contributes to the development of gut mucosal hyperpermeability and inflammation after HS/R.
| |
ACKNOWLEDGEMENTS |
|---|
This research was supported by National Institutes of Health Grants GM-53789, GM-37631, and GM-58484.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. P. Fink, Dept. of Critical Care Medicine, Scaife Hall, 3550 Terrace St., Pittsburgh, PA 15260 (E-mail: finkmp{at}ccm.upmc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
July 18, 2002;10.1152/ajpregu.00278.2002
Received 16 May 2002; accepted in final form 9 July 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Altavilla, D,
Saitta A,
Guarini S,
Galeano M,
Squadrito G,
Cucinotta D,
Santamaria LB,
Mazzeo AT,
Campo GM,
Ferlito M,
Minutoli L,
Bazzani C,
Bertolini A,
Caputi AP,
and
Squadrito F.
Oxidative stress causes nuclear factor-
B activation in acute hypovolemic hemorrhagic shock.
Free Radic Biol Med
30:
1055-1066,
2001[ISI][Medline].
2.
Ammori, BJ,
Leeder PC,
King RFGJ,
Barclay GR,
Martin IG,
Larvin M,
and
McMahon MJ.
Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality.
J Gastrointest Surg
3:
252-262,
1999[ISI][Medline].
3.
Ayala, A,
Perrin MM,
Meldrum DR,
Ertel W,
and
Chaudry IH.
Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin.
Cytokine
2:
170-174,
1999.
4.
Bahrami, S,
Yao YM,
Leichtfried G,
Redl H,
Schlag G,
and
Di Padova FE.
Monoclonal antibody to endotoxin attenuates hemorrhage-induced lung injury and mortality in rats.
Crit Care Med
25:
1030-1036,
1997[ISI][Medline].
5.
Bartizal, KF,
Salkowski C,
Pleasants JR,
and
Balish E.
The effect of microbial flora, diet, and age on the tumoricidal activity of natural killer cells.
J Leukoc Biol
36:
739-750,
1984[Abstract].
6.
Bauer, C,
Riemer-Paxian I,
Larsen R,
and
Arzi I.
Recombinant N-terminal fragment of bactericidal/permeability increasing protein (rBPI21) prevents shock-induced microcirculatory alterations in the liver.
Crit Care Med
25:
1283-1288,
1997[ISI][Medline].
7.
Bos, NA,
and
Ploplis VA.
Humoral immune response to 2,4-dinitrophenyl-keyhole limpet hemocyanin in antigen-free, germ-free and conventional BALB/c mice.
Eur J Immunol
24:
59-65,
1994[ISI][Medline].
8.
Cannon, WB.
Traumatic Shock. New York: Appleton, 1923.
9.
Cebra, JJ.
Influence of microbiota on intestinal immune system development.
Am J Clin Nutr
69, Suppl:
1046S-1051S,
1999
10.
Deitch, EA,
Bridges W,
Baker J,
Ma JW,
Ma L,
Grisham MB,
Granger DN,
Specian RD,
and
Berg R.
Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation.
Surgery
104:
191-198,
1988[ISI][Medline].
11.
Deitch, EA,
Morrison J,
Berg R,
and
Specian RD.
Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats.
Crit Care Med
18:
529-536,
1990[ISI][Medline].
12.
DeMaria, EJ,
Pellicane JV,
and
Lee RB.
Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor.
J Trauma
35:
720-724,
1999.
13.
Doig, CJ,
Sutherland LR,
Sandham JD,
Fick GH,
Verhoef M,
and
Meddings JB.
Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients.
Am J Respir Crit Care Med
158:
444-451,
1998
14.
Endo, S,
Inada K,
Yamada K,
Takakuwa T,
Kasai T,
Nakae H,
Yoshida M,
and
Ceska M.
Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock.
Crit Care Med
22:
949-955,
1994[ISI][Medline].
15.
Faries, PL,
Simon RJ,
Martella AT,
Lee MJ,
and
Machiedo GW.
Intestinal permeability correlates with severity of injury in trauma patients.
J Trauma
44:
1031-1036,
1998[ISI][Medline].
16.
Ferraro, FJ,
Rush BF, Jr,
Simonian GT,
Bruce CJ,
Murphy TF,
Hsieh JT,
Klein K,
and
Condon M.
A comparison of survival at different degrees of hemorrhagic shock in germ-free and germ-bearing rats.
Shock
4:
117-120,
1999.
17.
Fine, J,
Frank ED,
Rutenberg SH,
and
Schweinburg FB.
The bacterial factor in traumatic shock.
N Engl J Med
260:
214-216,
1959[ISI][Medline].
18.
Frank, H,
Jacob SW,
Schweinburg FB,
Goddard J,
and
Fine J.
Traumatic shock. XXI. Effectiveness of an antibiotic in experimental hemorrhagic shock.
Am J Physiol
168:
430-436,
1952
19.
Guo, W,
Ding J,
Huang Q,
Jerrells T,
and
Deitch EA.
Alterations in intestinal bacterial flora modulate the systemic cytokine response to hemorrhagic shock.
Am J Physiol Gastrointest Liver Physiol
269:
G827-G832,
1995
20.
Haskel, Y,
Xu D,
Lu Q,
and
Deitch EA.
Bombesin protects against bacterial translocation induced by three commercially available liquid enteral diets: a prospective, randomized multigroup trial.
Crit Care Med
22:
108-113,
1994[ISI][Medline].
21.
Heneghan, JB.
Hemorrhagic shock in unanesthetized gnotobiotic rats.
In: Advances in Germfree Research and Gnotobiology, edited by Miyakawa M,
and Luckey TD.. Cleveland, OH: CRC, 1968, p. 165-171.
22.
Heneghan, JB.
Response of germfree animals to shock.
J Med
21:
51-66,
1990[ISI][Medline].
23.
Ikeda, M,
Hamada K,
Sumitomo N,
Okamoto H,
and
Sakakibara B.
Serum amyloid A, cytokines, and corticosterone responses in germfree and conventional mice after lipopolysaccharide injection.
Biosci Biotechnol Biochem
63:
1006-1010,
1999.
24.
Jacob, S,
Weizel H,
Gordon E,
Korman H,
Schweinburg F,
Frank H,
and
Fine J.
Bacterial action in development of irreversibility to transfusion in hemorrhagic shock in the dog.
Am J Physiol
179:
523-531,
1954
25.
Jarrar, D,
Wang P,
Cioffi WG,
Bland KI,
and
Chaudry IH.
Critical role of oxygen radicals in the initiation of hepatic depression after trauma hemorrhage.
J Trauma
49:
879-885,
2000[ISI][Medline].
26.
Klaasen, HL,
Van der Heijden PJ,
Stok W,
Poelma FG,
Koopman JP,
Van den Brink ME,
Bakker MH,
Eling WM,
and
Beynen AC.
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice.
Infect Immun
61:
303-306,
1993
27.
Lakshminarayanan, V,
Drab-Weiss EA,
and
Roebuck KA.
H2O2 and tumor necrosis factor-
induce differential binding of the redox-responsive transcription factors AP-1 and NF-
B to the interleukin-8 promoter in endothelial and epithelial cells.
J Biol Chem
273:
32670-32678,
1998
28.
Langkamp-Henken, B,
Donovan TB,
Pate LM,
Maull CD,
and
Kudsk KA.
Increased intestinal permeability following blunt and penetrating trauma.
Crit Care Med
23:
660-664,
1995[ISI][Medline].
29.
Lillehei, RC.
The intestinal factor in irreversible hemorrhagic shock.
Surgery
42:
1043-1054,
1957[ISI][Medline].
30.
Livingston, DH,
Wang MT,
Hsieh J,
Murphy TF,
and
Rush BF, Jr.
Hemorrhagic shock inhibits lipopolysaccharide-induced myelopoiesis in both germ-free and conventional rats.
Surgery
112:
773-779,
1992[ISI][Medline].
31.
McNulty, WP, Jr,
and
Linares R.
Hemorrhagic shock of germfree rats.
Am J Physiol
198:
141-144,
1960
32.
Metchnikoff, E.
The nature of man.
In: Studies in Opportunistic Philosophy, edited by Mitchell PC.. New York: Putnam, 1908, p. 309.
33.
Minor, T,
Niessen F,
Klauke H,
and
Isselhard W.
No evidence for a protective effect of ascorbic acid on free radical generation and liver injury after hemorrhagic shock in rats.
Shock
5:
280-283,
1996[ISI][Medline].
34.
Moore, FA,
Moore EE,
Poggetti R,
McAnena OJ,
Peterson VM,
Abernathy CM,
and
Parsons PE.
Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma.
J Trauma
31:
629-638,
1991[ISI][Medline].
35.
Moreau, MC,
Ducluzeau R,
Guy-Grand D,
and
Muller MA.
Increase in the population of duodenal immunoglobulin A plasmacytes in axenic mice associated with different living or dead bacterial strains of intestinal origin.
Infect Immun
21:
532-539,
1978
36.
Morel, DR,
Skoskiewicz M,
Robinson DR,
Bloch KJ,
Hoaglin DC,
and
Zapol WM.
Leukotrienes, thromboxane A2 and prostaglandins during systemic anaphylaxis in sheep.
Am J Physiol Heart Circ Physiol
261:
H782-H792,
1991
37.
Mota-Filipe, H,
McDonald MC,
Cuzzocrea S,
and
Thiemermann C.
A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock.
Shock
12:
255-261,
1999[ISI][Medline].
38.
Nadler, AL,
and
Zweifach BW.
Pathogenesis of experimental shock. II. Absence of endotoxic activity in blood of rabbits subjected to graded hemorrhage.
J Exp Med
114:
195-204,
1961[Abstract].
39.
Nicaise, P,
Gleizes A,
Sandre C,
Forestier F,
Kergot R,
Quero AM,
and
Labarre C.
Influence of intestinal microflora on murine bone marrow and spleen macrophage precursors.
Scand J Immunol
48:
585-591,
1998[ISI][Medline].
40.
Oudemans-van Straaten, HM,
Jansen PG,
Hoek FJ,
van Deventer SJ,
Sturk A,
Stoutenbeek CP,
Tytgat GN,
Wildevuur CR,
and
Eysman L.
Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients.
J Cardiothorac Vasc Anesth
10:
187-194,
1996[ISI][Medline].
41.
Pape, HC,
Dwenger A,
Regel G,
Auf`m'Kolck M,
Gollub F,
Wisner D,
Sturm JA,
and
Tscherne H.
Increased gut permeability after multiple trauma.
Br J Surg
81:
850-852,
1994[ISI][Medline].
42.
Pellicane, JV,
Gore DC,
and
DeMaria EJ.
Decreased lactate in endotoxin-resistant mice undergoing hemorrhage is independent of tumor necrosis factor availability.
J Surg Res
56:
361-366,
1994[ISI][Medline].
43.
Pritts, TA,
Hungress ES,
Hershko DD,
Robb BW,
Sun X,
Luo GJ,
Fischer JE,
Wong HR,
and
Hasselgren PO.
Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells.
Am J Physiol Regul Integr Comp Physiol
282:
R1016-R1026,
2002
44.
Pritts, TA,
Moon MR,
Wang Q,
Hungress ES,
Salzman AL,
Fischer JE,
and
Hasselgren PO.
Activation of NF-
B varies in different regions of the gastrointestinal tract during endotoxemia.
Shock
14:
118-122,
2000[ISI][Medline].
45.
Ramana, CV,
Boldogh I,
Izumi T,
and
Mitra S.
Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals.
Proc Natl Acad Sci USA
95:
5061-5066,
2001
46.
Ranganathan, AC,
Nelson KK,
Rodriguez AM,
Kim KH,
Tower GB,
Rutter JL,
Brinckerhoff CE,
Huang TT,
Epstein CJ,
Jeffrey JJ,
and
Melendez JA.
Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation.
J Biol Chem
276:
14264-14270,
2001
47.
Ravin, HA,
Rowley D,
Jenkins C,
and
Fine J.
On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal.
J Exp Med
112:
783-792,
1960[Abstract].
48.
Rush, BF, Jr,
Redan JA,
Flanagan JJ, Jr,
Heneghan JB,
Hsieh J,
Murphy TF,
Smith S,
and
Machiedo GW.
Does the bacteremia observed in hemorrhagic shock have clinical significance? A study in germ-free animals.
Ann Surg
210:
342-345,
1989[ISI][Medline].
49.
Russell, DH,
Barreto JC,
Klemm K,
and
Miller TA.
Hemorrhagic shock increases gut macromolecular permeability in the rat.
Shock
4:
50-55,
1995[ISI][Medline].
50.
Sauaia, A,
Moore FA,
Moore EE,
Norris JM,
Lezotte DC,
and
Hamman RF.
Multiple organ failure can be predicted as early as 12 hours after injury.
J Trauma
45:
301-303,
1998.
51.
Schaedler, RW,
Dubos R,
and
Costello R.
Association of germfree mice with bacteria isolated from normal mice.
J Exp Med
122:
77-83,
1965[Abstract].
52.
Schwartz, MD,
Repine JE,
and
Abraham E.
Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock.
Am J Respir Cell Mol Biol
12:
434-440,
1995[Abstract].
53.
Shenkar, R,
and
Abraham E.
Hemorrhage induces rapid in vivo activation of CREB and NF-
B in murine intraparenchymal lung mononuclear cells.
Am J Respir Cell Mol Biol
16:
145-152,
1997[Abstract].
54.
Shenkar, R,
and
Abraham E.
Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-
B, and cyclic AMP response element binding protein.
J Immunol
163:
954-962,
1999
55.
Shenkar, R,
Yum HK,
Arcaroli J,
Kupfner J,
and
Abraham E.
Interactions between CBP, NF-
B, and CREB in the lungs after hemorrhage and endotoxemia.
Am J Physiol Lung Cell Mol Physiol
281:
L418-L426,
2001
56.
Spain, DA,
Fruchterman TM,
Matheson PJ,
Wilson MA,
Martin AW,
and
Garrison RN.
Complement activation mediates intestinal injury after resuscitation from hemorrhagic shock.
J Trauma
46:
224-233,
1999[ISI][Medline].
57.
Tan, S,
Yokoyama Y,
Dickens E,
Cash TG,
Freeman BA,
and
Parks DA.
Xanthine oxidase activity in the circulation of rats following hemorrhagic shock.
Free Radic Biol Med
15:
407-414,
1993[ISI][Medline].
58.
Tawadrous, ZS,
Delude RL,
and
Fink MP.
Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats.
Shock
17:
473-477,
2002[ISI][Medline].
59.
Wang, Q,
Fang CH,
and
Hasselgren PO.
Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice.
Am J Physiol Regul Integr Comp Physiol
281:
R1013-R1023,
2001
60.
Wang, W,
Chaudry IH,
and
Wang P.
Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6.
J Surg Res
79:
39-46,
1998[ISI][Medline].
61.
Wattanasirichaigoon, S,
Menconi MJ,
Delude RL,
and
Fink MP.
Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats.
Shock
12:
127-133,
1999[ISI][Medline].
62.
Wattanasirichaigoon, S,
Menconi MJ,
Delude RL,
and
Fink MP.
Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion.
Shock
11:
269-275,
1999[ISI][Medline].
63.
Wattanasirichaigoon, S,
Menconi MJ,
and
Fink MP.
Lisofylline ameliorates intestinal and hepatic injury induced by hemorrhage and resuscitation in rats.
Crit Care Med
28:
1540-1549,
2000[ISI][Medline].
64.
Yamashita, M.
Bactericidal/permeability-increasing protein ameliorates hypercoagulability after hemorrhagic shock.
Thromb Res
87:
323-329,
1997[ISI][Medline].
65.
Yang, R,
Gallo DJ,
Baust JJ,
Uchiyama T,
Watkins SK,
Delude RL,
and
Fink MP.
Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock.
Am J Physiol Gastrointest Liver Physiol
283:
G212-G222,
2002
66.
Yao, YM,
Bahrami S,
Leichtfried G,
Redl H,
and
Schlag G.
Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.
Ann Surg
221:
398-405,
1995[ISI][Medline].
67.
Yao, YM,
Tian HM,
Sheng ZY,
Wang YP,
Sun SR,
and
Xu SH.
Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin/bacterial translocation and cytokine formation in rats.
J Trauma
38:
924-930,
1995[ISI][Medline].
68.
Zweifach, BW,
Gordon HA,
Wagner M,
and
Reyniers JA.
Irreversible hemorrhagic shock in germfree rats.
J Exp Med
107:
437-450,
1958[Abstract].
This article has been cited by other articles:
![]() |
|